Onco Wiki / Disease

Burkitt Lymphoma

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

IDDIS-BURKITT
TypeDisease
Aliases
BLЛімфома Беркітта
Statusreviewed 2026-04-25 | pending_clinical_signoff
DiseasesNone declared
SourcesSRC-NCCN-BCELL-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Source YAML

icd_o_3_morphology9687/3
icd_10C83.7
who_classificationAggressive B-cell lymphomas — Burkitt lymphoma per WHO 5th ed.

Capabilities

Notes

Highly proliferative — risk of severe TLS at first dose. CNS prophylaxis mandatory (HD-MTX systemic + IT MTX/cytarabine). HIV testing mandatory at diagnosis. Time-sensitive but NOT "emergency-room time-critical" in CHARTER §15.2 C2 sense (treatment is outpatient/inpatient hematology pathway, not bedside emergency); we generate a Plan.

Used By

Actionability

Algorithms

Disease

Indication

Questionnaires

Red flag

Sources